Skip to main content
. Author manuscript; available in PMC: 2014 Sep 14.
Published in final edited form as: Breast Cancer Res Treat. 2013 Sep 14;141(2):287–297. doi: 10.1007/s10549-013-2690-z

Table 3.

The Association of TGF-β signaling pathway genes and breast cancer risk stratified by menopausal status

Gene (SNP) Genotype Pre/peri-menopause (n= 2,827)
Post-menopause (n =4,679)
p-intb
Controls
(n = 1,306)
Cases
(n = 1,521)
ORa (95 % CI) Contros
(n = 21,105)
Cases
(n = 2,574)
ORa (95 % CI)
N (%) N (%) N (%) N (%)
RUNX1 TT/TC 1,480 97.3 1,273 97.5 1.00 2,515 97.7 2,033 96.6 1.00 0.10 (0.77)
  (rs2268288) CC 41 2.7 33 2.5 0.88 (0.55, 1.41) 59 2.3 71 3.4 1.47 (1.03, 2.09)
RUNX3 CC 1,009 66.3 774 59.3 1.00 1,619 63.0 1,301 61.9 1.00 0.01 (0.08)
  (rs906296) CG/GG 512 33.7 532 40.7 1.33 (1.14, 1.55) 952 37.0 802 38.1 1.05 (0.93, 1.18)
RUNX3 GG/GA 1,504 98.9 1,293 99.0 1.00 2,546 99.0 2,068 98.2 1.00 0.21 (1.00)
  (rs4478762) AA 16 1.1 13 1.0 0.98 (0.47, 2.05) 27 1.0 37 1.8 1.71 (1.04, 2.82)

Bold text designates significant associations at the 0.05 level (within strata) after adjustment for multiple comparisons

a

Odds Ratios adjusted for age, study, and genetic admixture (n = 7,506; missing observations: menopausal status (n = 227)

b

Interaction p-value (SNP × menopause); Bonferroni p-value for adjustment for multiple comparisons shown in parentheses